TABLE 4.
Correlation of Serum V (ng/ml) with Urinary V Clearance (mg/24hours) for Individual Patients
| Patient ID | # Samples Used in Analysis (n)a |
Correlation Coefficient (R2) |
|---|---|---|
| 25V-1 | 6 | 0.932 |
| 25V-3 | 7 | 0.209 |
| 50V-1 | 6 | 0.228 |
| 50V-2 | 7 | 0.817 |
| 50V-3 | 6 | 0.424 |
| 50V-4 | 6 | 0.927 |
| 50V-5 | 6 | 0.170 |
| 100V-1 | 7 | 0.345 |
| 100V-2 | 7 | 0.331 |
| 100V-3 | 7 | 0.364 |
| 100V-4 | 6 | 0.758 |
| 100V-5 | 7 | 0.971 |
| 100V-7 | 6 | 0.521 |
| 100V-8 | 5 | 0.510 |
a
A maximum of seven samples is possible for this analysis as done, the five samples collected during vanadium dosing and two samples after dosing was completed (the last sample, day 84, was omitted from this analysis). Patients with less than seven samples used in their analyses either had a missing serum or urine sample.